معرفی
Peter Bullock is a Professor in the Department of Developmental, Molecular and Chemical Biology at the Tufts University School of Medicine. He holds expertise in virology, molecular biology, and antiviral drug development. His research focuses on understanding the molecular mechanisms of polyomavirus replication and identifying inhibitors of T-antigen, a key viral protein.
Educational Background:
- Ph.D., University of California, Berkeley, 1984
- M.Sc., SUNY Albany, 1977
- B.A., SUNY Plattsburgh, 1974
Research Interests:
- Polyomavirus replication mechanisms
- Development of antiviral therapies targeting T-antigen
- Structural biology of viral proteins
- Role of polyomaviruses in human diseases like PML, renal dysfunction, and Merkel cell carcinoma
Grants & Funding:
- National Multiple Sclerosis Society: 'Elimination of PML via Development of a Genetic Screen for Inhibitors of T-Antigen' (2011–2012)
- National Institute of Allergy and Infectious Diseases: 'A Chemical Genetic Approach to Inhibiting T-ag Assembly on the Viral Origin' (2007–2009)
Teaching & Professional Activities:
- Teaches graduate-level biochemistry courses, including 'Graduate Biochemistry' and 'Biochemistry Foundations in Neuroscience'
- Serves on editorial review boards for journals like Journal of Virology, Nature, and PLoS Pathogens
- Active in university committees, including the Basic Science Faculty Appointments Promotions and Tenure Committee
Labs & Collaborations: Engaged in collaborative research projects focused on structural biology and antiviral drug discovery, leveraging high-throughput screening and computational modeling (e.g., AlphaFold2).
۰مقاله ثبتشده
